New mobile age being accelerated by COVID-19

The U.S. Food and Drug Administration's validation requirements process for drug development is a good model for healthcare artificial intelligence governance, explains Michael Abrams, managing partner at Numerof & Associates.

The Philadelphia health system has committed to returning 10 million hours back to patient care over the next three years using AI, says Dr. Baligh Yehia, president of Jefferson Health.

Switching cardiology patients to Bluetooth-enabled medical devices that send data to patient portals is helping to reduce chronic care complexities, says Sutter Health CCIO Dr. Richard Milani and Patient Experience R&D lead Trevor Berceau.